United States· US:0363-0811_8ea8066c-1cdc-49f7-a99a-a432e82293ef
Allergy Nasal
A triamcinolone product containing triamcinolone acetonide, registered in United States by Walgreen Company. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 11 of 19 countries.
Countries holding a registration under ATC R01AD11 (triamcinolone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Triamcinolone · ATC R01AD11
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIAMCINOLONE ACETONIDE
- Manufacturer
- Walgreen Company
- Country
- United States (US)
- ATC code
- R01AD11
- ATC class
- Triamcinolone
- Defined daily dose
- 0.22 mg, N
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1103630811011 BOTTLE in 1 CARTON (0363-0811-01) / 120 SPRAY, METERED in 1 BOTTLE
- ndc1103630811021 BOTTLE in 1 CARTON (0363-0811-02) / 60 SPRAY, METERED in 1 BOTTLE
- ndc1103630811032 BOTTLE in 1 CARTON (0363-0811-03) / 120 SPRAY, METERED in 1 BOTTLE
- ndc110363-0811-01
- ndc110363-0811-02
- ndc110363-0811-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
38 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
38 records
- 38 moderate
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triamcinolone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- FinlandAftabMeda Oy
- Japanトリアムシノロンアセトニドビーブランド・メディコーデンタル
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c7da0de-1c19-4197-9ac7-bfdf2110aa43 GET /v1/drugs/9c7da0de-1c19-4197-9ac7-bfdf2110aa43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"source": "ndc",
"strength": "55",
"substance": "TRIAMCINOLONE ACETONIDE",
"productndc": "0363-0811",
"dosage_form": "SPRAY, METERED",
"dea_schedule": null,
"strength_unit": "ug/1",
"application_number": "ANDA078104",
"marketing_category": "ANDA"
}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.